← Open Payments lookup

MISTY LANCE: Open Payments

NPI 1750838983 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,518 in 132 payments from 17 companies in 2025. Trend: 2023 $1,801 · 2024 $2,282 · 2025 $2,518

Food & beverage: $2,434Education: $84
CompanyPaymentsAmount
Janssen Biotech, Inc.21$388
Takeda Pharmaceuticals U.S.A., Inc.20$347
ABBVIE INC.19$233
Gilead Sciences, Inc.10$220
GENZYME CORPORATION8$203
Madrigal Pharmaceuticals10$195
QOL Medical, LLC7$172
Phathom Pharmaceuticals, Inc.12$166
Amgen Inc.1$117
Regeneron Healthcare Solutions, Inc.6$115

Products named: TREMFYA, ENTYVIO, DUPIXENT, REZDIFFRA, Sucraid, VOQUEZNA, UPLIZNA, IBSRELA.

Industry payments across TX — which companies pay providers there.